Burkly Linda (CIK 1985604) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-05). Recent activity: Sell EDIT (731 shares), Sell EDIT (749 shares), Sell EDIT (713 shares), Sell EDIT (710 shares), Sell EDIT (5,121 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 731 | $1,975 |
| 2026-03-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 749 | $1,513 |
| 2025-12-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 713 | $1,533 |
| 2025-09-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 710 | $1,846 |
| 2025-08-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 5,121 | $12,751 |
| 2025-06-04 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 726 | $1,249 |
| 2025-03-05 | Editas Medicine, Inc. (EDIT) | EVP, CHIEF SCIENTIFIC OFFICER | Sell | 2,891 | $4,944 |
Source: SEC Form 4 filings · as of 2026-06-05